[1] |
Schwartz L, Anteby R, Klang E, et al. Stroke mortality prediction using machine learning: Systematic review[J]. J Neurol Sci, 2023, 444:120529.
|
[2] |
Wang YJ, Li ZX, Gu HQ, et al. China Stroke Statistics Writing Committee. China stroke statistics: An update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J]. Stroke Vasc Neurol, 2022, 7(5):415-450.
|
[3] |
Ma Q, Li R, Wang L, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: An analysis for the global burden of disease study 2019[J/OL]. Lancet Public Health, 2021, 6:e897-906.
|
[4] |
Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258):1204-1222.
|
[5] |
Wu S, Wu B, Liu M, et al. China Stroke Study Collaboration. Stroke in China: Advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4):394-405.
|
[6] |
Chao BH, Yan F, Hua Y, et al. Stroke prevention and control system in China: CSPPC-Stroke Program[J]. Int J Stroke, 2021, 16(3):265-272.
|
[7] |
Lin X, Wang H, Rong X, et al. Exploring stroke risk and prevention in China: Insights from an outlier[J]. Aging (Albany NY), 2021, 13(11):15659-15673.
|
[8] |
Feigin VL, Nguyen G, Cercy K, et al. GBD 2016 Lifetime Risk of Stroke Collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016[J]. N Engl J Med, 2018, 379(25):2429-2437.
|
[9] |
Wang W, Jiang B, Sun H, et al. NESS-China Investigators. Prevalence, incidence, and mortality of stroke in China: Results from a nationwide population-based survey of 480 687 adults[J]. Circulation, 2017, 135(8):759-771.
|
[10] |
Zhao Y, Hua X, Ren X, et al. Increasing burden of stroke in China: A systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality[J]. Int J Stroke, 2023, 18(3):259-267.
|
[11] |
Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013-2018[J]. JAMA, 2021, 326(24):2498-2506.
|
[12] |
Wang L, Zhou B, Zhao Z, et al. Body-mass index and obesity in urban and rural China: Findings from consecutive nationally representative surveys during 2004-2018[J]. Lancet, 2021, 398(10294):53-63.
|
[13] |
Hu S, Cui B, Mlynash M, et al. Stroke epidemiology and stroke policies in China from 1980 to 2017: A systematic review and meta-analysis[J]. Int J Stroke, 2020, 15(1):18-28.
|
[14] |
Qi J, Adair T, Chowdhury HR, et al. Estimating causes of out-of-hospital deaths in China: Application of SmartVA methods[J]. Popul Health Metr, 2021, 19(1):25.
|
[15] |
马林,巢宝华,曹雷,等.2007—2017年中国脑卒中流行趋势及特征分析[J/CD].中华脑血管病杂志(电子版),2020,14(5):253-258.
|
[16] |
王淼,范美娟,张黎波.2007—2019年天津市河西区脑卒中死亡流行特征和趋势分析[J].上海预防医学,2021,33(11):1001-1006.
|
[17] |
Yang G, Kong L, Zhao W, et al. Emergence of chronic non-communicable diseases in China[J]. Lancet, 2008, 372(9650):1697-705.
|
[18] |
Wu S, Wu B, Liu M, et al. China Stroke Study Collaboration. Stroke in China: Advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4):394-405.
|
[19] |
王陇德,彭斌,张鸿祺,等.《中国脑卒中防治报告2020》概要[J].中国脑血管病杂志,2022,19(2):136-144.
|
[20] |
Satoh M, Ohkubo T, Asayama K, et al. EPOCH-JAPAN Research Group. Lifetime risk of stroke and coronary heart disease deaths according to blood pressure level: EPOCH-JAPAN (evidence for cardiovascular prevention from observational cohorts in Japan)[J]. Hypertension, 2019, 73(1):52-59.
|
[21] |
Tu WJ, Zhao Z, Yin P, et al. Estimated burden of stroke in China in 2020[J/OL]. JAMA Netw Open, 2023, 6(3):e231455.
|
[22] |
Chen X, Liu L, Liu M, et al. Hypertensive retinopathy and the risk of stroke among hypertensive adults in China[J]. Invest Ophthalmol Vis Sci, 2021, 62(9):28.
|
[23] |
Markus HS, Leung T. Stroke in China[J]. Int J Stroke, 2023, 18(3):256-258.
|
[24] |
Yang P, Song L, Zhang Y, et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): A multicentre, open-label, blinded-endpoint, randomised controlled trial[J]. Lancet, 2022, 400(10363):1585-1596.
|